Success Metrics

Clinical Success Rate

50.0%

Based on 1 completed trials

Completion Rate

50%(1/2)

Active Trials

2(40%)

Results Posted

0%(0 trials)

Terminated

1(20%)

Phase Distribution

Ph not_applicable

60%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

N/ANon-phased studies

3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(1)

Terminated(1)

Detailed Status

Recruiting2

Completed1

Not yet recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed120%

not_yet_recruiting120%

terminated120%

recruiting240%

Recent Activity

2 active trials

Showing 5 of 5

recruitingnot_applicable

CongenItal Naevus Cohort for Longitudinal Evaluation

NCT06828822

recruitingnot_applicable

BETAmethasone Dose Reduction: Non-Inferiority on the Neurocognitive Outcomes of Children Born Before 32 Weeks of Gestation

NCT04021485

completed

Clinical Trials (5)

Showing 5 of 5 trials

NCT06828822Not Applicable

CongenItal Naevus Cohort for Longitudinal Evaluation

Recruiting

NCT04021485Not Applicable

BETAmethasone Dose Reduction: Non-Inferiority on the Neurocognitive Outcomes of Children Born Before 32 Weeks of Gestation

Recruiting

NCT05712512

Experimental Techniques for Early Identification of Autism

Completed

NCT06574386Not Applicable

Pregnancy in GUCH Patients

Not Yet Recruiting

NCT03834987

NGLY1 Deficiency: A Prospective Natural History Study

Terminated

All 5 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 5